Getting The Deal Through logo
Getting The Deal Through

US bans pharmacist “gag clauses”

Pharma - News – 11 September 2018

The US Senate has unanimously passed a bill banning Medicare insurers from using “gag clauses” to stop pharmacies from telling patients how to obtain cheaper drugs.

Damages balloon to US$1.8bn in Adocia/Eli Lilly arbitration

Pharma - News – 11 September 2018

French biopharmaceutical company Adocia has announced that it has updated the amount of damages it is claiming in arbitration proceedings against Eli Lilly to US$1.8 billion, up from US$200 million when the claim was filed in February.

FDA appoints new top lawyer

Pharma - News – 11 September 2018

The US Food and Drug Administration (FDA) has announced that senior White House lawyer Stacy Cline Amin will be its next chief counsel.

Lawyers welcome UK’s “no-deal” Brexit notices, but warn of “serious decisions” to come

Pharma - News – 04 September 2018

Pharma lawyers and industry groups have said the UK government’s publication of a series of planning papers on the impact of a “no-deal” Brexit on the sector is “good news” for companies that have long been demanding clarity on the possible repercussions of such a scenario, but have also noted the huge regulatory burden it will impose.

Covington advises Emergent on US$735m opioid treatment acquisition

Pharma - News – 04 September 2018

A team from Covington & Burling has guided US biopharma company Emergent Biosolutions in its US$735 million buy-out of opioid treatment maker Adapt Pharma.

Wilson Sonsini recruits Hogan Lovells partner in DC

Pharma - News – 04 September 2018

Wilson Sonsini Goodrich & Rosati has recruited Hogan Lovells corporate partner Daniel Keating as a member of its global generic pharmaceutical industry group in Washington, DC.

Follow Getting the Deal Through for the latest updates on law and regulation worldwide

Follow us on LinkedIn